Health Policy's Home Turf
Washington, DC, is home to Ogilvy PR's Health Policy Group and the senior level counselors who provide health policy communications expertise to the agency's clients. From specialty pharmaceutical companies to medical device manufacturers to industry associations, the Health Policy Group brings inside-the-Beltway insights and communications expertise to our clients. With international reach through Ogilvy PR's global network, we provide solutions to communicating and shaping health policy issues wherever they may arise.
Could Health Policy Get Any More Challenging?
Drug pricing, formulary placement, reimbursement, patent challenges, DTC/DTP promotion practices, ethics, media and Congressional scrutiny of the pharmaceutical and medical device industries and general skepticism are just some of the issues confronting healthcare and healthcare-related companies and their executives. These intersecting issues not only affect bottom line revenues but impact corporate and product brand equity in ways that continue to evolve over time.
Developing effective communications strategies around top policy issues, understanding how the work of product marketing teams and government relations departments can ultimately be complimentary rather than fragmented and siloed is where we excel. We seek to engage our clients' product teams and policy people, understanding that the actions of one affect the outcomes for all.
The Power of Advocacy
Few understand the power of innovation and promise of new drug and device exploration better than the patients and the patient advocacy groups who directly benefit from life-altering and life-changing treatments. We seek to harness the power of advocacy, helping create stronger relationships and enhancing dialogue.
The Health Policy Group At Work
The core competencies of the Health Policy Group are policy communications, issue management and advocacy relations. The following represents some of our work:
The Health Policy Group offers: